161 related articles for article (PubMed ID: 29264937)
21. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
[TBL] [Abstract][Full Text] [Related]
22. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
[TBL] [Abstract][Full Text] [Related]
23. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
24. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
[TBL] [Abstract][Full Text] [Related]
25. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting.
Deliberato RO; Marra AR; Sanches PR; Martino MD; Ferreira CE; Pasternak J; Paes AT; Pinto LM; dos Santos OF; Edmond MB
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):266-71. PubMed ID: 23711530
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
[TBL] [Abstract][Full Text] [Related]
27. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
Schuetz P; Raad I; Amin DN
Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.
Kristoffersen KB; Søgaard OS; Wejse C; Black FT; Greve T; Tarp B; Storgaard M; Sodemann M
Clin Microbiol Infect; 2009 May; 15(5):481-7. PubMed ID: 19416298
[TBL] [Abstract][Full Text] [Related]
29. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use.
Schuetz P; Beishuizen A; Broyles M; Ferrer R; Gavazzi G; Gluck EH; González Del Castillo J; Jensen JU; Kanizsai PL; Kwa ALH; Krueger S; Luyt CE; Oppert M; Plebani M; Shlyapnikov SA; Toccafondi G; Townsend J; Welte T; Saeed K
Clin Chem Lab Med; 2019 Aug; 57(9):1308-1318. PubMed ID: 30721141
[TBL] [Abstract][Full Text] [Related]
30. Procalcitonin-guided antibiotic therapy duration in critically ill adults.
Walker C
AACN Adv Crit Care; 2015; 26(2):99-106. PubMed ID: 25898876
[TBL] [Abstract][Full Text] [Related]
31. Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study.
Chromik AM; Endter F; Uhl W; Thiede A; Reith HB; Mittelkötter U
Langenbecks Arch Surg; 2006 Jun; 391(3):187-94. PubMed ID: 16369855
[TBL] [Abstract][Full Text] [Related]
32. [Procalcitonin as biomarker for infections].
de Jonge JC; de Lange DW; Bij de Vaate EA; van Leeuwen H; Arends JE
Ned Tijdschr Geneeskd; 2016; 160():D282. PubMed ID: 27734774
[TBL] [Abstract][Full Text] [Related]
33. Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients.
Demissei BG; Cleland JG; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Davison B; Givertz MM; Bloomfield DM; Dittrich H; van Veldhuisen DJ; Hillege HL; Voors AA; Cotter G
Int J Cardiol; 2016 Feb; 204():164-71. PubMed ID: 26666342
[TBL] [Abstract][Full Text] [Related]
34. Procalcitonin-guided diagnosis and antibiotic stewardship revisited.
Sager R; Kutz A; Mueller B; Schuetz P
BMC Med; 2017 Jan; 15(1):15. PubMed ID: 28114931
[TBL] [Abstract][Full Text] [Related]
35. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
[TBL] [Abstract][Full Text] [Related]
36. Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases.
Magrini L; Travaglino F; Marino R; Ferri E; De Berardinis B; Cardelli P; Salerno G; Di Somma S
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():133-42. PubMed ID: 23436675
[TBL] [Abstract][Full Text] [Related]
37. Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study.
van der Does Y; Limper M; Schuit SC; Poley MJ; van Rosmalen J; Ramakers C; Patka P; van Gorp EC; Rood PP
BMC Emerg Med; 2016 Apr; 16():17. PubMed ID: 27048405
[TBL] [Abstract][Full Text] [Related]
38. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial.
Manzano S; Bailey B; Girodias JB; Galetto-Lacour A; Cousineau J; Delvin E
Am J Emerg Med; 2010 Jul; 28(6):647-53. PubMed ID: 20637377
[TBL] [Abstract][Full Text] [Related]
39. Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department.
Hausfater P; Juillien G; Madonna-Py B; Haroche J; Bernard M; Riou B
Crit Care; 2007; 11(3):R60. PubMed ID: 17521430
[TBL] [Abstract][Full Text] [Related]
40. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
